Mothaffar Rimawi

23PUBLICATIONS
243CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpidemiological modellingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 04, 2026
Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.

|Mar 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results.

Rashmi K Murthy, Barbara J O'Brien, Donald A Berry

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Apr 03, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.

Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter

|Jul 01, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.

Maggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston

|Jun 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa

Pageof 4

Frequent Collaborators

7 joint publications

Antonio C Wolff

7 joint publications

Ian Krop

6 joint publications

Rita Nanda

5 joint publications

Eric P Winer